

Health Care: Drugs
Cempra Inc (CEMP: NASDAQ)
$6.61 -0.07 | -1.05%
05/21/13 - 11:44 AM ET
1.88K / 20.10K
Vol / Avg. Vol:
6.61 / 6.68
Open / Prev. Close:
6.60 - 6.61
Today's Range:
Portfolios with CEMP
Latest CEMP Headlines from TheStreet
More Financial News for CEMP
Press Releases for CEMP
- Cempra, Inc. To Report First Quarter 2013 Financial And Operating Results, And Host Conference Call And Webcast On April 25, 2013 - PR Newswire 04.18.13 | 04:04 pm
- Cempra, Inc. To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.26.13 | 04:02 pm
- Cempra, Inc. To Report Fourth Quarter And Full Year 2012 Financial And Operating Results, And Host Conference Call And Webcast On February 28, 2013 - PR Newswire 02.21.13 | 04:02 pm
- Grant Awarded To Study Novel Therapies For Muco-Obstructive Diseases Includes Studies On Cempra's Solithromycin (CEM-101) In A Cystic Fibrosis Anti-inflammatory Model - PR Newswire 02.12.13 | 08:02 am
- Cempra, Inc. To Present At BIO CEO & Investor Conference And Leerink Swann Global Healthcare Conference - PR Newswire 02.05.13 | 04:02 pm
- Cempra, Inc. Announces Initiation Of Oral Solithromycin Global Phase 3 Clinical Trial In Patients With Community-Acquired Bacterial Pneumonia - PR Newswire 12.19.12 | 08:12 am
- Cempra, Inc. Announces Initiation Of CEM-102 Phase 2 Clinical Trial In Patients With Prosthetic Joint Infections - PR Newswire 12.14.12 | 08:12 am
- Cempra, Inc. To Present At Oppenheimer 23rd Annual Healthcare Conference - PR Newswire 12.05.12 | 04:12 pm
- Cempra, Inc. To Present At The Jefferies 2012 Global Healthcare Conference In London - PR Newswire 11.09.12 | 08:11 am
- Cempra, Inc. To Report Third Quarter 2012 Financial And Operating Results, And Host Conference Call And Webcast On November 8, 2012 - PR Newswire 11.01.12 | 08:11 am
See All Press Releases
Partner Headlines for CEMP